Penam Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 17-12-2024
- Paid Up Capital ₹ 1.50 Cr
as on 17-12-2024
- Company Age 19 Year, 6 Months
- Last Filing with ROC 31 Mar 2014
- Open Charges ₹ 5.67 Cr
as on 17-12-2024
- Satisfied Charges ₹ 2.83 Cr
as on 17-12-2024
About Penam Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2014. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.50 Cr.
The company currently has active open charges totaling ₹5.67 Cr. The company has closed loans amounting to ₹2.83 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ashok Aggarwal, Ravi Aggarwal, and Deepak Bansal serve as directors at the Company.
- CIN/LLPIN
U24232UP2005PTC030191
- Company No.
030191
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jun 2005
- Date of AGM
30 Sep 2014
- Date of Balance Sheet
31 Mar 2014
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Rampur, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Penam Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Aggarwal  | Director | 28-Aug-2012 | Current |
| Ravi Aggarwal | Director | 07-Feb-2008 | Current |
| Deepak Bansal | Director | 20-Feb-2008 | Current |
Financial Performance of Penam Pharmaceuticals.
Enhance accessibility to Penam Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Penam Pharmaceuticals?
Unlock access to Penam Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 05 Jul 2008 | ₹5.67 Cr | Open |
Oriental Bank Of Commerce Creation Date: 13 Oct 2006 | ₹3.50 M | Satisfied |
Oriental Bank Of Commerce Creation Date: 13 Oct 2006 | ₹7.80 M | Satisfied |
How Many Employees Work at Penam Pharmaceuticals?
Unlock and access historical data on people associated with Penam Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Penam Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Penam Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
